Vanguard Portfolio Management’s Achieve Life Sciences ACHV Stock Holding History

Vanguard Portfolio Management’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.51M	Buy	+537,596	New	+$2.56M	﹤0.01%	2543

Other funds holding ACHV

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Portfolio Management's ACHV Position: Q2 2026 in Review

Vanguard Portfolio Management opened a new position in Achieve Life Sciences (ACHV) in Q2 2026: 537,596 shares worth $3.51M. The stake represents ﹤0.01% of the portfolio and ranks #2543 among its holdings.

110 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

Vanguard Portfolio Management held 537,596 shares of Achieve Life Sciences worth $3.51M as of Q2 2026.
Achieve Life Sciences was a new Vanguard Portfolio Management position in Q2 2026.
Achieve Life Sciences made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2543 holding.
110 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.